MDXG
MiMedx Group, Inc. NASDAQ Listed Feb 12, 2008$3.67
After hrs
$3.67
+0.00%
Mkt Cap $549.5M
52w Low $3.09
11.9% of range
52w High $7.96
50d MA $3.59
200d MA $5.46
P/E (TTM)
18.0x
EV/EBITDA
7.0x
P/B
2.1x
Debt/Equity
0.1x
ROE
12.6%
P/FCF
7.5x
RSI (14)
55.80
ATR (14)
$0.13
Beta
1.65
50d MA
$3.59
200d MA
$5.46
Avg Volume
1.4M
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a semi-permeable protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications; and AMNIOBURN a semi-permeable protective barrier allograft used in the treatment of partial-thickness and full-thickness burns, as well as lead product includes mdHACM, a micronized form of AMNIOFIX, supplied in powder form. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.
1775 West Oak Commons Court, NE · Marietta, GA 30062 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | AMC | -0.07 | -0.05 | +28.6% | 3.09 | -1.3% | +8.7% | +9.5% | -1.9% | +0.8% | +0.5% | — |
| Feb 25, 2026 | AMC | 0.09 | 0.14 | +55.6% | 5.28 | -0.8% | -6.4% | -1.0% | -0.2% | -2.5% | +1.3% | — |
| Oct 29, 2025 | AMC | 0.07 | 0.15 | +114.3% | 7.19 | +6.8% | +2.9% | +3.4% | -1.7% | +2.3% | +3.5% | — |
| Jul 30, 2025 | AMC | 0.06 | 0.10 | +66.7% | 6.52 | +16.6% | +10.3% | -0.4% | -0.1% | -2.5% | +3.9% | — |
| Apr 30, 2025 | AMC | 0.06 | 0.06 | +0.0% | 6.88 | -4.1% | -8.1% | +0.0% | +4.7% | -0.2% | +5.6% | — |
| Feb 26, 2025 | AMC | 0.07 | 0.07 | +0.0% | 8.01 | -5.1% | +1.6% | +3.2% | -1.2% | -2.4% | -0.1% | — |
| Oct 30, 2024 | AMC | 0.04 | 0.05 | +13.6% | 5.69 | +9.3% | +20.4% | +1.2% | +2.9% | +2.2% | +2.9% | — |
| Jul 31, 2024 | AMC | 0.08 | 0.08 | +0.0% | 7.45 | -12.8% | -10.3% | -3.3% | -3.3% | +2.1% | -1.7% | — |
| Apr 30, 2024 | AMC | 0.05 | 0.07 | +40.0% | 6.16 | +4.9% | +18.7% | +2.6% | -1.7% | -3.3% | +2.2% | — |
| Feb 28, 2024 | AMC | 0.08 | 0.04 | -50.0% | 8.20 | +9.8% | -0.5% | +5.8% | -4.3% | -3.1% | +0.9% | — |
| Oct 30, 2023 | AMC | 0.05 | 0.06 | +20.0% | 6.32 | +2.7% | +3.8% | -1.7% | +0.6% | +5.1% | -1.9% | — |
| Aug 1, 2023 | AMC | 0.01 | 0.01 | +100.4% | 7.93 | +7.8% | -2.9% | +0.6% | -0.3% | -3.6% | -1.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 | Citizens | Maintains | Market Outperform → Market Outperform | — | $3.09 | $3.05 | -1.3% | +8.7% | +9.5% | -1.9% | +0.8% | +0.5% |
| Apr 20 | Citizens | Maintains | Market Outperform → Market Outperform | — | $3.42 | $3.37 | -1.5% | -5.0% | -1.5% | +3.4% | +1.2% | +2.4% |
| Apr 17 | Craig-Hallum | Maintains | Buy → Buy | — | $3.43 | $3.46 | +0.9% | -0.3% | -5.0% | -1.5% | +3.4% | +1.2% |
| Feb 17 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $5.12 | $5.11 | -0.2% | +0.8% | +1.2% | -0.4% | -0.6% | +3.1% |
| Jan 20 | Lake Street | Maintains | Buy → Buy | — | $5.42 | $5.25 | -3.1% | -0.6% | -1.1% | +1.7% | -3.0% | -0.2% |
| Dec 17 | Mizuho | Maintains | Outperform → Outperform | — | $7.25 | $7.20 | -0.7% | -2.2% | +2.3% | -2.8% | -0.1% | -0.6% |
| Jul 31 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $6.52 | $7.60 | +16.6% | +10.3% | -0.4% | -0.1% | -2.5% | +3.9% |
| Jul 15 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $6.80 | $6.26 | -7.9% | -6.9% | +6.0% | +0.1% | -4.5% | +3.6% |
| Feb 27 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $8.01 | $7.60 | -5.1% | +1.6% | +3.2% | -1.2% | -2.4% | -0.1% |
| Aug 1 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $7.45 | $6.50 | -12.8% | -10.3% | -3.3% | -3.3% | +2.1% | -1.7% |
| Aug 1 | Craig-Hallum | Maintains | Buy → Buy | — | $7.45 | $6.50 | -12.8% | -10.3% | -3.3% | -3.3% | +2.1% | -1.7% |
| May 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.16 | $6.46 | +4.9% | +18.7% | +2.6% | -1.7% | -3.3% | +2.2% |
| Mar 1 | Mizuho | Maintains | Buy → Buy | — | $8.16 | $8.31 | +1.8% | +5.8% | -4.3% | -3.1% | +0.9% | +1.0% |
| Oct 31 | Mizuho | Maintains | Buy → Buy | — | $6.32 | $6.49 | +2.7% | +3.8% | -1.7% | +0.6% | +5.1% | -1.9% |
| Aug 2 | Mizuho | Maintains | Buy → Buy | — | $7.93 | $8.55 | +7.8% | -2.9% | +0.6% | -0.3% | -3.6% | -1.6% |
| Aug 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.93 | $8.55 | +7.8% | -2.9% | +0.6% | -0.3% | -3.6% | -1.6% |
| Jun 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.85 | $5.71 | -2.4% | +7.2% | +1.6% | +1.3% | -1.6% | +0.8% |
| May 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.81 | $4.47 | +17.3% | +39.4% | +4.1% | +3.8% | +1.4% | +2.1% |
| Mar 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.18 | $4.15 | -0.7% | -6.5% | +13.0% | -3.6% | -1.4% | -3.8% |
| Oct 13 | Mizuho | Maintains | Buy → Buy | — | $2.70 | $2.83 | +4.8% | +11.5% | -4.0% | +5.2% | -1.3% | -1.3% |
| Sep 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.42 | $3.50 | +2.3% | -2.3% | +2.4% | -0.9% | +4.1% | -2.0% |
| Sep 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.28 | $6.28 | +0.0% | -11.3% | +0.4% | -1.3% | +11.4% | -4.6% |
| Jul 26 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $11.82 | $12.14 | +2.7% | +2.1% | -1.4% | +3.0% | -1.3% | +1.3% |
| Mar 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.81 | $9.30 | +5.6% | +15.2% | +4.1% | +1.7% | -6.0% | -2.7% |
| Feb 26 | Lake Street | Downgrade | Buy → Hold | — | $7.83 | $7.90 | +0.9% | -6.1% | -1.1% | -2.5% | +0.3% | +6.8% |
| Feb 20 | Needham | Downgrade | Strong Buy → Hold | — | $14.47 | $9.90 | -31.6% | -39.5% | +3.4% | -1.9% | -11.8% | -6.1% |
| May 23 | First Analysis | Downgrade | Equal Weight → Underweight | — | $14.33 | $13.55 | -5.4% | -5.0% | -0.2% | +1.5% | -2.9% | +1.1% |
| Mar 3 | Piper Sandler | Maintains | Overweight → Overweight | — | $8.35 | $8.50 | +1.8% | +0.0% | -2.3% | +1.5% | +0.6% | +1.3% |
| Dec 12 | UBS | Maintains | Sell → Sell | — | $9.56 | $9.19 | -3.9% | -4.7% | +1.1% | -0.2% | -0.1% | -6.4% |
| Nov 8 | Aegis Capital | Maintains | Buy → Buy | — | $8.46 | $8.54 | +0.9% | +3.0% | +6.0% | -1.8% | +2.8% | +4.4% |
| Apr 19 | Lake Street | Maintains | Buy → Buy | — | $8.41 | $8.30 | -1.3% | -3.3% | -0.2% | +1.8% | -1.9% | -3.3% |
| Nov 16 | Needham | Upgrade | Buy → Strong Buy | — | $7.75 | $8.00 | +3.2% | +6.2% | -1.3% | +3.0% | -3.0% | +3.2% |
| Oct 30 | Northland Securities | Upgrade | Market Perform → Outperform | — | $7.29 | $7.89 | +8.2% | -0.1% | +7.3% | -5.4% | +2.2% | -0.7% |
| Oct 30 | Northland Capital Markets | Upgrade | Market Perform → Outperform | — | $7.29 | $7.89 | +8.2% | -0.1% | +7.3% | -5.4% | +2.2% | -0.7% |
| Jul 29 | Needham | Downgrade | Strong Buy → Buy | — | $12.80 | $12.10 | -5.5% | -3.0% | -10.2% | -3.8% | -4.8% | -3.3% |
| Jul 17 | Brean Capital | Maintains | Buy → Buy | — | $12.42 | $12.76 | +2.7% | +4.4% | -0.2% | -0.3% | -1.5% | -1.7% |
| May 14 | Northland Capital Markets | Upgrade | Underperform → Market Perform | — | $9.67 | $9.75 | +0.8% | +2.4% | +0.9% | +1.3% | +1.2% | +2.1% |
| May 14 | Northland Securities | Upgrade | Underperform → Market Perform | — | $9.67 | $9.75 | +0.8% | +2.4% | +0.9% | +1.3% | +1.2% | +2.1% |
| Feb 27 | Needham | Downgrade | Strong Buy → Buy | — | $10.48 | $10.47 | -0.1% | -1.2% | -1.0% | -0.5% | -1.8% | +3.1% |
| Feb 20 | Needham | Upgrade | Buy → Strong Buy | — | $9.38 | $9.96 | +6.2% | +5.1% | -2.6% | -0.5% | -0.3% | +10.1% |
| Oct 15 | Canaccord Genuity | Maintains | Buy → Buy | — | $7.94 | $8.00 | +0.8% | +10.8% | -3.5% | -2.4% | +1.2% | +3.1% |
| Jul 15 | Needham | Maintains | Buy → Buy | — | $7.01 | $7.22 | +3.0% | +0.1% | -3.6% | -5.8% | +3.6% | -2.0% |
| Oct 4 | Canaccord Genuity | Maintains | Buy → Buy | — | $4.53 | $4.85 | +7.1% | +6.0% | +2.1% | +0.2% | -7.1% | +8.3% |
| Aug 20 | Lake Street | Maintains | Buy → Buy | — | $5.58 | $5.66 | +1.4% | +4.5% | +1.2% | +1.7% | +3.8% | -0.6% |
No insider trades available.
8-K · 5.03
! Medium
MiMedx Group, Inc. -- 8-K 5.03: Amendment to Articles / Bylaws
Jun 16
8-K · 7.01
! Medium
MiMedx Group, Inc -- 8-K 7.01: Regulation FD Disclosure
MiMedx Group will host a Q1 2026 earnings call on April 29, 2026, providing investors with financial results and operating updates through a conference call and webcast presentation.
Apr 29
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
MDXG's executive change could signal management transition risks or strategic shifts; investors should monitor the replacement executive's background and strategic direction for impact on company performance.
Apr 16
8-K · 7.01
! Medium
MiMedx Group, Inc -- 8-K 7.01: Regulation FD Disclosure
MiMedx Group will host an earnings call on February 25, 2026 at 4:30 PM ET to discuss Q4 and full-year 2025 financial results, with presentation materials available for investor review.
Feb 25
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Essex Woodlands Management, Inc. | 28,195,249 | $111M | — | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 5,166,006 | $20M | New | Mar 2026 |
| 3 | Renaissance Technologies Llc | 3,019,871 | $12M | Added | Mar 2026 |
| 4 | Morgan Stanley | 1,455,566 | $10M | Reduced | Dec 2025 |
| 5 | Marshall Wace, Llp | 1,861,146 | $7M | Added | Mar 2026 |
| 6 | Phocas Financial Corp. | 985,982 | $7M | Added | Dec 2025 |
| 7 | Qube Research & Technologies Ltd | 1,651,519 | $7M | Added | Mar 2026 |
| 8 | Op Asset Management Ltd | 1,218,224 | $5M | Added | Mar 2026 |
| 9 | Vanguard Portfolio Management Llc | 1,105,718 | $4M | New | Mar 2026 |
| 10 | Meros Investment Management, Lp | 1,093,028 | $4M | Reduced | Mar 2026 |
| 11 | Northern Trust Corp | 1,023,106 | $4M | Added | Mar 2026 |
| 12 | Aqr Capital Management Llc | 912,728 | $4M | Added | Mar 2026 |
| 13 | Citadel Advisors Llc | 776,441 | $3M | Added | Mar 2026 |
| 14 | Arrowstreet Capital, Limited Partnership | 775,841 | $3M | Added | Mar 2026 |
| 15 | Ubs Group Ag | 673,002 | $3M | Added | Mar 2026 |
| 16 | Prudential Financial Inc | 668,730 | $3M | Added | Mar 2026 |
| 17 | Bank Of America Corp /de/ | 572,295 | $2M | Added | Mar 2026 |
| 18 | First Trust Advisors Lp | 553,320 | $2M | Added | Mar 2026 |
| 19 | Los Angeles Capital Management Llc | 518,847 | $2M | Added | Mar 2026 |
| 20 | Jane Street Group, Llc | 259,262 | $2M | — | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$549.5M
Enterprise Value
$399.8M
P/E (TTM)
17.96x
Forward P/E
47.05x
PEG Ratio
1.49x
P/B
2.11x
P/S
1.41x
P/FCF
7.53x
EV/EBITDA
6.98x
Shares Out
149.7M
Financials (TTM)
Revenue
$389.4M
Net Income
$30.7M
EBITDA
$57.3M
Free Cash Flow
$73.0M
Op Cash Flow
$74.0M
EPS Basic
$0.33
EPS Diluted
$0.20
EPS Forward
$0.08
Gross Margin
81.0%
Op Margin
10.2%
Net Margin
7.9%
Balance Sheet
Total Assets
$342.7M
Total Liab.
$86.1M
Total Equity
$256.5M
Cash
$166.1M
LT Debt
$16.5M
Book Value/Sh
$1.74
Debt/Equity
0.09x
Current Ratio
4.32
Quick Ratio
3.92
Returns & Growth
ROE
12.6%
ROA
9.9%
ROIC
16.7%
Rev Growth YoY
+20.0%
EPS Growth YoY
+13.8%
Price Returns
2W
+3.7%
1M
+9.5%
3M
-24.7%
6M
-46.5%
12M
-42.8%
Technicals
52W High
$7.96
52W Low
$3.09
50d MA
$3.59
200d MA
$5.46
RSI (14)
55.80
ATR (14)
$0.13
Beta
1.65
Avg Volume
1.4M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$10.00
High
$10.00
Low
$10.00
Median
$10.00
Data updated apr 26, 2026 11:45am
· Source: financialmodelingprep.com